Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Protein Science : a Publication of the Protein Society|November 22, 2025
Metadynamics simulations and site-directed mutagenesis determine the binding of cannabidiol to the adenosine A2A receptorAleix Quintana-Garcia, Iu Raïch, Claudia Del Llinas Del Torrent, et al.
Experimental Neurology|January 12, 2023
The cannabinoid CB1 receptor interacts with the angiotensin AT2 receptor. Overexpression of AT2-CB1 receptor heteromers in the striatum of 6-hydroxydopamine hemilesioned ratsRafael Rivas-Santisteban, Jaume Lillo, Iu Raïch, et al.
Cellular and Molecular Gastroenterology and Hepatology|April 17, 2021
The Heteromeric Complex Formed by Dopamine Receptor D5 and CCR9 Leads the Gut Homing of CD4+ T Cells Upon InflammationFrancisco Osorio-Barrios, Gemma Navarro, Javier Campos, et al.
International Journal of Molecular Sciences|September 9, 2022
Regulation of Expression of Cannabinoid CB2 and Serotonin 5HT1A Receptor Complexes by Cannabinoids in Animal Models of Hypoxia and in Oxygen/Glucose-Deprived NeuronsJaume Lillo, Iu Raïch, Laura Silva, et al.
ACS Pharmacology & Translational Science|September 19, 2025
Cannabinoid CB1 Receptor Activation Mitigates N‑Methyl‑d‑aspartate Receptor-Mediated NeurotoxicityGemma Navarro, Iu Raïch, Joan Biel Rebassa, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 26, 2023
Pharmacological insights emerging from the characterization of a large collection of synthetic cannabinoid receptor agonists designer drugsClaudia Gioé-Gallo, Sandra Ortigueira, José Brea, et al.
Journal of Chemical Information and Modeling|August 30, 2023
The Leu/Val6.51 Side Chain of Cannabinoid Receptors Regulates the Binding Mode of the Alkyl Chain of Δ9-TetrahydrocannabinolClaudia Llinas Del Torrent, Iu Raïch, Angel Gonzalez, et al.
Pharmacological Research|November 10, 2021
Similarities and differences upon binding of naturally occurring Δ9-tetrahydrocannabinol-derivatives to cannabinoid CB1 and CB2 receptorsIu Raïch, Rafael Rivas-Santisteban, Alejandro Lillo, et al.
Pharmacological Research|May 30, 2020
Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB1, CB2 and CB1/CB2 heteromer receptorsGemma Navarro, Katia Varani, Alejandro Lillo, et al.
International Journal of Molecular Sciences|October 29, 2025
The Heteromeric Dopamine Receptor D2:D3 Controls the Gut Recruitment and Suppressive Activity of Regulatory T-CellsJacob Mora, Iu Raïch, Valentina Ugalde, et al.
Pageof 4